Pinnacle Life Science Pvt. Ltd: A Legacy of Excellence in Healthcare
Established in 2015, Pinnacle Life Science Pvt. Ltd is a proud subsidiary of Aarti Drugs Ltd (ADL) and is an integral part of the esteemed Aarti Group of Industries, a $ 1.5 billion conglomerate. With a rich legacy of 35 years in healthcare through Aarti Drugs Ltd, we have expanded our horizons in every direction, specializing in bulk APIs, intermediates, and finished formulations.
At Pinnacle, we take pride in our extensive portfolio, which encompasses medications for both acute and chronic ailments. Our production prowess is evident with an annual capacity of producing 3 billion tablets and 300 million capsules.
Global Footprint
Our global presence spans across North America, Central America, Latin America (including Brazil and Mexico), Europe, UK, the MENA region, French West Africa, East Africa, Australia, Central Asia, and Southeast Asia.
We are proud to announce our partnership with 250+ esteemed clients, reflecting our commitment to excellence and collaboration. Our global footprint is evident with our presence in 90+ countries. As part of our growth strategy, we are actively seeking partnerships to expand our operations in regions including Australia, Central America, China, North America, Canada, Brazil, EU, New Zealand, South Africa, and Latin America.
State-of-the-Art Manufacturing
Pinnacle boasts two cutting-edge cGMP-compliant manufacturing facilities in India, catering to a wide range of therapeutic categories such as Anti-Diabetic, Anti-Cancer, Anti-Bacterials, Anti-Protozoal, Anti-Fungal, Anti-Allergic, Anti-Hypertensive, Anthelmintics, Gastrointestinal, and Analgesics.
At Pinnacle, we believe in collaborative growth. We are open to various business models, including Licensing & Supplies, Co-Development, Contract Development, Contract Manufacturing, and Tech Transfer with API supplies.
Leave a Reply